A novel gene fusion RUNX1/ZNF423 promotes leukemic relapse of NUP98-rearranged AML

被引：0
|
作者：
Wenxin Du
Zhimei Xia
Zebin Luo
Yichang Chen
Shaowei Bing
Wei Wang
Xingya Zhang
Zhan Zhou
Jingying Zhang
Ji Cao
Bo Yang
Qiaojun He
Xuejing Shao
Xiaojun Xu
Meidan Ying
机构：
[1] Zhejiang University,Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti
[2] Children’s Hospital,Cancer Drug Research, College of Pharmaceutical Sciences
[3] Zhejiang University School of Medicine,Division of Hematology
[4] National Clinical Research Center for Child Health,Oncology
[5] College of Pharmaceutical Sciences and Alibaba-Zhejiang University Joint Research Center of Future Digital Healthcare,Innovation Institute for Artificial Intelligence in Medicine, Zhejiang Provincial Key Laboratory of Anti
[6] Zhejiang University,Cancer Drug Research
[7] Ministry of Education,Engineering Research Center of Innovative Anticancer Drugs
[8] Zhejiang University,Cancer Center
来源：
Leukemia | 2023年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2286 / 2291
页数：5
相关论文
共 38 条
  • [31] TRANSCRIPTIONALLY ACTIVE CHIMERIC GENE DERIVED FROM THE FUSION OF THE AML1 GENE AND A NOVEL GENE ON CHROMOSOME-8 IN T(8, 21) LEUKEMIC-CELLS
    NISSON, PE
    WATKINS, PC
    SACCHI, N
    CANCER GENETICS AND CYTOGENETICS, 1992, 63 (02) : 81 - 88
  • [32] NUP98-NSD1 Fusion Gene Is Strongly Associated with a Poor Prognosis in Pediatric Acute Myeloid Leukemia: A Study of the Japanese Childhood AML99 Cooperative Study Group
    Shiba, Norio
    Taki, Tomohiko
    Park, Myoung-ja
    Murata, Chisato
    Oki, Kentaro
    Ichikawa, Hitoshi
    Shimada, Akira
    Kanazawa, Takashi
    Sotomatsu, Manabu
    Tabuchi, Ken
    Adachi, Souichi
    Tawa, Akio
    Horibe, Keizo
    Tsuchida, Masahiro
    Hanada, Ryoji
    Tsukimoto, Ichiro
    Arakawa, Hirokazu
    Hayashi, Yasuhide
    BLOOD, 2011, 118 (21) : 641 - 641
  • [33] t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression
    Okumura, Akiko J.
    Peterson, Luke F.
    Okumura, Fumihiko
    Boyapati, Anita
    Zhang, Dong-Er
    BLOOD, 2008, 112 (04) : 1392 - 1401
  • [34] A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin specific protease gene USP42
    Paulsson, K.
    Bekassy, A.
    Olofsson, T.
    Johansson, B.
    Panagopoulos, I.
    CHROMOSOME RESEARCH, 2005, 13 : 147 - 147
  • [35] A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42
    Paulsson, K
    Békássy, AN
    Olofsson, T
    Mitelman, F
    Johansson, B
    Panagopoulos, I
    LEUKEMIA, 2006, 20 (02) : 224 - 229
  • [36] A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42
    K Paulsson
    A N Békássy
    T Olofsson
    F Mitelman
    B Johansson
    I Panagopoulos
    Leukemia, 2006, 20 : 224 - 229
  • [37] Two novel leukemia cell lines useful for developing new molecular target therapy:: Kasumi-6, an AML-M2 cell line (Kasumi-6) with a mutated C/EBPα gene and Kasumi-5 with a NUP98-RAP1GDS1 fusion gene making it sensitive to RhoA kinase inhibitor, Y27632.
    Asou, H
    Tanaka, H
    Kimura, A
    Kamada, N
    Koeffler, HP
    BLOOD, 2001, 98 (11) : 562A - 562A
  • [38] Novel NUP98-HOXC11 fusion gene resulted from a chromosomal break within exon 1 of HOXC11 in acute myeloid leukemia with t(11;12)(p15;q13)
    Taketani, T
    Taki, T
    Shibuya, N
    Kikuchi, A
    Hanada, R
    Hayashi, Y
    CANCER RESEARCH, 2002, 62 (16) : 4571 - 4574
1234